hydralazine has been researched along with temocapril hydrochloride in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koike, H; Miyamoto, M; Sada, T | 1 |
Iijima, Y; Koike, H; Nishino, H; Oda, T; Oizumi, K; Sada, T | 1 |
Araki, H; Gomita, Y; Kawasaki, H; Mimaki, Y; Nakatsuma, A; Okazaki, M | 1 |
Abe, Y; Kimura, S; Kiyomoto, H; Kobori, H; Kohno, M; Miyata, K; Miyatake, A; Nagai, Y; Nishiyama, A; Ozawa, Y; Shokoji, T; Yao, L; Yukimura, T | 1 |
Akiyama, S; Gessei-Tsutsumi, N; Goda, M; Hobara, N; Kawasaki, H; Kurosaki, Y; Takayama, F | 1 |
1 trial(s) available for hydralazine and temocapril hydrochloride
Article | Year |
---|---|
Long-term inhibition of angiotensin converting enzyme suppresses calcium channel agonist-induced contraction of aorta in hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Calcium Channel Agonists; Calcium Chloride; Dose-Response Relationship, Drug; Hydralazine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Potassium Chloride; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thiazepines | 1989 |
4 other study(ies) available for hydralazine and temocapril hydrochloride
Article | Year |
---|---|
Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Heart; Hydralazine; Kidney; Male; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Thiazepines | 1988 |
Long-term treatment with angiotensin converting enzyme inhibitor restores reduced calcitonin gene-related peptide-containing vasodilator nerve function in mesenteric artery of spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Captopril; Electric Stimulation; Hydralazine; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Pindolol; Rats; Rats, Inbred SHR; Thiazepines; Time Factors; Vascular Resistance; Vasodilation | 1999 |
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Hydralazine; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; NADPH Oxidases; Olmesartan Medoxomil; Prediabetic State; Rats; Rats, Inbred OLETF; Receptors, Angiotensin; Renin; Tetrazoles; Thiazepines; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta | 2005 |
Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats.
Topics: Aging; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcitonin Gene-Related Peptide; Cell Count; Hydralazine; Hypertension; Immunohistochemistry; Losartan; Male; Mesenteric Arteries; Nerve Fibers; Neuropeptide Y; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Sympathetic Nervous System; Thiazepines; Vasodilator Agents | 2005 |